Cannabis Clinical Trials

Photo: Getty More and more people, young and old, are fast becoming fans of legalized weed, Jeff Sessions notwithstanding. That popularity has been greatly aided by the proliferation of laws that allow it to be used as a medical treatment, not just in the U.S., but in other countries such as Canada, which legalized medical […]

by

In an overcrowded field of cultivators vying for maximum yield, CannaRoyalty Corp. (CSE:CRZ) (OTCQX:CNNRF) is noteworthy for their rich tapestry of diversified holdings in the cannabis sector. It is a unique long-term strategy in an industry riddled with companies born with the intention of being acquired and anxious investors overcome with panic about the fear […]

by

(As Marijuana Business Daily ramps up its coverage of the global cannabis market, it’s launching a series examining recent marijuana legalization and business developments worldwide. The first few installments will focus on Latin America, starting with Chile and Argentina.) While Canada and the United States dominated marijuana headlines over the past year, their neighbors in […]

by

The MGC Pharmaceuticals Ltd (ASX: MXC) share price has been a solid performer on Wednesday. At the time of writing the cannabis company’s shares are 4.5% higher at 11.5 cents. What happened? This morning the company announced that its range of MGC Derma and Derma Plus products has been officially launched on leading global online […]

by

“As a pharmaceutical product, it is the subject of rigorous and intense manufacturing controls. Patients have the reassurance that the product is what we say it is and what they think it is,” Justin Gover, GW’s chief executive officer, told the Post. … read more at: https://www.salon.com/2018/02/10/big-pharma-green-lights-cannabis-based-drug-for-epilepsy_partner/

by

One of Australia’s highest-profile medicinal cannabis suppliers is prepared to face nine-years’ jail in a court case that could set a national legal precedent. Adelaide woman Jenny Hallam, 45, was raided by police in January last year, halting the supply of her cannabis oil to almost 300 Australians suffering from a range of medical conditions. […]

by

Tilray, a Canadian medical cannabis startup, has raised $60 million in a Series A financing. The company, owned and funded since its founding in 2014 by U.S. cannabis private equity firm Privateer Holdings, was backed in the Series A for the first time by unidentified institutional investors. Tilray researches, cultivates, processes and distributes medical cannabis and cannabinoids. Headquartered […]

by

Researchers say the groundbreaking trial will help prescribing and health policy Cannabis has been used for treatment in other conditions such as Parkinson’s The project will be led by a research team from the University of Queensland  By Matt Leclere For Daily Mail Australia Published: 06:13 EST, 3 February 2018 | Updated: 06:17 EST, 3 […]

by

Highlights: PTL’s Phase 2 open label clinical trial is aimed at measuring safety and efficacy of Satipharm CBD capsules for reducing seizure frequency in children with refractory, or treatment-resistant, epilepsy. Satipharm CBD capsules are a proprietary oral formulation developed using the Gelpell-CBD™ product technology. Satipharm CBD capsules reduced monthly seizure frequency in the treatment-resistant children […]

by